Clinical Trials & Safety
This track examines regulatory protocols governing human studies for advanced biological products. Topics highlight toxicity screening, tumorigenicity evaluation, patient monitoring frameworks, and adverse event tracking. Regulatory officers at Stem Cells 2027 will discuss international compliance pathways. Attendees will analyze biosafety clinical protocols and strict cellular therapy regulation to protect participant well-being.